Department of Medicine, University Medical Centre Mainz, Mainz, Germany, (3)Madrigal Pharmaceuticals, (4)Houston Research Institute, Houston, TX, (5)Sorbonne Universit, Assistance Publique-Hpitaux De Paris, Hpital Piti Salptrire, Institute of Cardiometabolism and Nutrition (ICAN), (6)Pinnacle Clinical Research Center, San Antonio, TX Background: MAESTRO-NASH (NCT03900429) is an ongoing 54-month, randomized, double-blind, placebo-controlled Phase 3 trial evaluating the efficacy of resmetirom in patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH) and fibrosis
New molecular mechanisms to reduce arsenic in crops
doi: 10.1016/j.clim.2023.109778 82 DangQSunZWangYWangLLiuZHanX
join the flour products, can play a role of reduction.Not only make the time of making bread reduced to half of the original or a third, labor conditions greatly improved, and a food nutrition reinforcement and other functions